Polydopamine Nanoparticle as a Stable and Capacious Nano-Reservoir of Rifampicin

Authors: Tasnuva Tamanna, Aimin Yu

Abstract:

Application of nanoscience in biomedical field has come across as a new era. This study involves the synthesis of nano drug carrier with antibiotic loading. Based on the founding that polydopamine (PDA) nanoparticles could be formed via self-polymerization of dopamine at alkaline pH, one-step synthesis of rifampicin coupled polydopamine (PDA-R) nanoparticles was achieved by adding rifampicin into the dopamine solution. The successful yield of PDA nanoparticles with or without the presence of rifampicin during the polymerization process was characterized by scanning electron microscopy, Fourier transform infrared spectroscopy, and Raman spectroscopy. Drug loading was monitored by UV-vis spectroscopy and the loading efficiency of rifampicin was calculated to be 76%. Such highly capacious nano-reservoir was found very stable with little drug leakage at pH 3.

Keywords: Drug loading, nanoparticles, polydopamine, rifampicin.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1339065

References:

[1] A. Postma et al, “Self-Polymerization of dopamine as a versatile and robust technique to prepare polymer capsules,” Chem. Mater., vol. 21, no. 14, pp. 3042-3044, Apr. 2009.
[2] Y. Ren et al, “Facile, high efficiency immobilization of lipase enzyme on magnetic iron oxide nanoparticles via a biomimetic coating,” BMC Biotechnol., vol. 11, pp. 1-8, Apr. 2011.
[3] H. Lee, J. Rho, P. B. Messersmith, “Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings,” Adv. Mater., vol. 21, no. 4, pp. 431, Apr. 2009.
[4] X. Zhang et al, “Biocompatible polydopamine fluorescent organic nanoparticles: facile preparation and cell imaging,” Nanoscale, vol. 4, no. 18, pp. 5581-5584, Apr. 2012.
[5] C. C. Ho, S. J. Ding, “The pH-controlled nanoparticles size of polydopamine for anti-cancer drug delivery,” J. Mater. Sci. Mater. Med., vol. 24, no. 10, pp. 2381-2390, Apr. 2013.
[6] J. Cui et al, “Immobilization and intracellular delivery of an anticancer drug using mussel-inspired polydopamine capsules,” Biomacromolecules, vol. 13, no. 8, pp. 2225-2228, Apr. 2012.
[7] Q. Liu, B. Yu, W. Ye, F. Zhou, “Highly selective uptake and release of charged molecules by pH-responsive polydopamine microcapsules,” Macromol. Biosci., vol. 11, no. 9, pp. 1227-1234, Apr. 2011.
[8] Q. Zheng et al, “Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release,” Int. J. of Pharm., vol. 463, no. 1, pp. 22-26, Apr. 2014.
[9] R. Liu, Y. Guo, G. Odusote, F. Qu, R. D. Priestley, “Core–shell Fe3O4 polydopamine nanoparticles serve multipurpose as drug carrier, catalyst support and carbon adsorbent,” ACS Appl. Mater. Interfaces, vol. 5, no. 18, pp. 9167-9171, Apr. 2013.
[10] S. Murali, J.-L. Chang, J.-M. Zen, “Bismuth oxide nanoparticles as a nanoscale guide to form a silver–polydopamine hybrid electrocatalyst with enhanced activity and stability for the oxygen reduction reaction,” RSC Adv., vol. 5, no. 6, pp. 4286-4291, Apr. 2015.
[11] W. Lee et al, “Fabricaton of polydopamine embedded reduced graphene oxide paper (Published Conference Proceedings style),” in 18th Int.Conf. on Composite Materials, South Korea.
[12] B. Fei et al, “Coating carbon nanotubes by spontaneous oxidative polymerization of dopamine,” Carbon, vol. 46, no. 13, pp. 1795-1797, Apr. 2008.
[13] G. Yeroslavsky, M. Richman, L. Dawidowicz, S. Rahimipour, “Sonochemically produced polydopamine nanocapsules with selective antimicrobial activity (in Suppl. Info.),” Chem. Commun., vol. 49, no. 51, pp. 5721-5723, Apr. 2013.
[14] T. Sasaki, H. Matsuura, K. Tanaka, “Preparation and drug-release kinetics of porous poly (l-lactic acid)/rifampicin blend particles,” ISRN Polymer Science, Apr. 2014.